Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

FDA grants breakthrough therapy designation for Tafamidis

May 24, 2018

Acceleron initiates phase II PULSAR study of sotatercept in pulmonary arterial hypertension

May 23, 2018

Daewoong Pharmaceutical presents TNF-alpha production inhibitors

May 18, 2018

Qingdao Marine Biomedical Research Institute patents ROS-production inhibitors

May 18, 2018

EC approves Repatha for prevention of heart attack and stroke in established cardiovascular disease

May 17, 2018

Caladrius Biosciences initiates phase II study of CLBS-14

May 17, 2018

Novartis describes novel IKACh channel blockers

May 9, 2018

Procella and Smartwise establish cardiovascular collaboration with AstraZeneca

May 8, 2018

First patient dosed in phase II study of AG-10 in ATTR cardiomyopathy

May 4, 2018

Bristol-Myers Squibb presents new apelin receptor agonists

May 4, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...